Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_2104_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
13.10.2026
Размер:
2 Мб
Скачать
☆
Abdominal Aortic Aneurysms and Periodontitis 109
[12] Mattila KJ, Nieminen MS, Valtonen VV, Rasi VP, Kesäniemi YA,
Syrjälä SL, Jungell PS, Isoluoma M, Hietaniemi K, Jokinen MJ.
Association between dental health and acute myocardial infarction. BMJ
1989; 298: 779-781.
[13] Sakurai K, Wang D, Suzuki J, Umeda M, Nagasawa T, Izumi Y,
Ishikawa I, Isobe M. High incidence of actinobacillus
actinomycetemcomitans infection in acute coronary syndrome. Int Heart
J 2007; 48: 663-675.
[14] Mendez MV, Scott T, LaMorte W, Vokonas P, Menzoian JO, Garcia R.
An association between periodontal disease and peripheral vascular
disease. Am J Surg 1998; 176: 153-157.
[15] Kurihara N, Inoue Y, Iwai T, Umeda M, Huang Y, Ishikawa I. Detection
and localization of periodontopathic bacteria in abdominal aortic
aneurysms. Eur J Vasc Endovasc Surg 2004; 28: 553-558.
[16] Paraskevas KI, Mikhailidis DP, Giannoukas AD. Periodontitis and
abdominal aortic aneurysms: a random association or a pathogenetic
link? Int Angiol 2009; 28: 431-433.
[17] Delbosc S, Alsac JM, Journe C, Louedec L, Castier Y, Bonnaure-Mallet
M, Ruimy R, Rossignol P, Bouchard P, Michel JB, Meilhac O.
Porphyromonas gingivalis participates in pathogenesis of human
abdominal aortic aneurysm by neutrophil activation. Proof of concept in
rats. PLoS One 2011; 6: e18679.
[18] Aoyama N, Suzuki J, Wang D, Ogawa M, Kobayashi N, Hanatani T,
Takeuchi Y, Izumi Y, Isobe M. Porphyromonas gingivalis promotes
murine abdominal aortic aneurysms via matrix metalloproteinase-2
induction. J Periodontal Res. 2011; 46: 176-183.
[19] Aoyama N, Suzuki J, Ogawa M, Watanabe R, Kobayashi N, Hanatani T,
Yoshida A, Ashigaki N, Izumi Y, Isobe M. Clarithromycin suppresses
the periodontal bacteria-accelerated abdominal aortic aneurysms in mice.
J Periodontal Res 2012; 47: 463-469.
[20] Aoyama N, Suzuki J, Ogawa M, Watanabe R, Kobayashi N, Hanatani T,
Ashigaki N, Sekinishi A, Izumi Y, Isobe M. Toll-like receptor-2 plays a
fundamental role in periodontal bacteria-accelerated abdominal aortic
aneurysms. Circ J 2013; 77: 1565-1573.
[21] Suzuki J, Aoyama N, Aoki M, Tada Y, Wakayama
K, Akazawa H,
Shigematsu K, Hoshina
K, Izumi
Y, Komuro I, Miyata
T, Hirata
Y, Isobe
M. High incidence of periodontitis in Japanese patients with abdominal
aortic aneurysm. Int Heart J 2014; 55: 268-270.
Jun-ichi Suzuki and Norio Aoyama 110
[22] Suzuki J, Aoyama N, Aoki M, Tada Y, Wakayama
K, Akazawa H,
Shigematsu K, Hoshina K, Izumi Y, Komuro I, Miyata T, Hirata Y,
Isobe M. Incidence of periodontitis in Japanese patients with
cardiovascular diseases -A comparison between abdominal aortic
aneurysm and arrhythmia. Heart Vessels 2014 Apr 16. [Epub ahead of
print]
[23] Aas JA, Paster BJ, Stokes LN, Olsen I, Dewhirst FE. Defining the
normal bacterial flora of the oral cavity. J Clin Microbiol 2005; 43:
5721–5732.
[24] Paster BJ, Olsen I, Aas JA, Dewhirst FE. The breadth of bacterial
diversity in the human periodontal pocket and other oral sites.
Periodontology 2000 2005; 42: 80–87.
[25] Yang HW, Huang YF, Chou MY. Occurrence of Porphyromonas
gingivalis and Tannerella forsythensis in periodontally diseased and
healthy subjects. J Periodontol 2004; 75: 1077–1083.
[26] van Winkelhoff AJ, Loos BG, van der Reijden WA, van der Velden U.
Porphyromonas gingivalis, Bacteroides forsythus and other putative
periodontal pathogens in subjects with and without periodontal
destruction. J Clin Periodontol 2002; 29: 1023–1028.
[27] Haffajee AD, Cugini MA, Dibart S, Smith C, Kent RL Jr, Socransky SS.
The effect of SRP on the clinical and microbiological parameters of
periodontal diseases. J Clin Periodontol 1997; 24: 324–334.
[28] Fujise O, Hamachi T, Inoue K, Miura M, Maeda K. Microbiological
markers for prediction and assessment of treatment outcome following
non-surgical periodontal therapy. J Periodontol 2002; 73: 1253–1259.
[29] Hajishengallis G, Liang S, Payne MA Hashim A, Jotwani R, Eskan MA,
McIntosh ML, Alsam A, Kirkwood KL, Lambris JD, Darveau RP,
Curtis MA.. Low-abundance biofilm species orchestrates inflammatory
periodontal disease through the commensal microbiota and complement.
Cell Host Microbe 2011; 10: 497–506.
[30] Lamont RJ, Jenkinson HF. Life below the gum line: pathogenic
mechanisms of Porphyromonas gingivalis. Microbiol Mol Biol Rev
1998; 62: 1244–1263.
[31] Vlachojannis C, Dye BA, Herrera-Abreu M, Pikdöken L, Lerche-Sehm
J, Pretzl B, Celenti R, Papapanou PN. Determinants of serum IgG
responses to periodontal bacteria in a nationally representative sample of
US adults. J Clin Periodontol 2010; 37: 685-696.

INDEX

A
abuse, 4, 23
access, 5, 40, 41, 44
acidosis, 32, 33, 34, 35, 48, 51, 53
Acinetobacter baumannii, 71, 82, 83, 84
actinomycosis, 69
acute renal failure, viii, 68
adenosine, 34
adhesion(s), 39, 41, 42, 43, 46, 48, 49
adolescents, 5
adults, vii, ix, 2, 11, 18, 22, 36, 58, 87, 88,
89, 90, 95, 98, 99, 100, 102, 108, 110
advancement, vii, 1
adventitia, 104
adverse effects, 76
adverse event, x, 88
aerobic bacteria, 70
aeruginosa infections, 75, 82
agar, 58
age, 2, 4, 6, 11, 15, 17, 26, 37, 88, 89, 95,
96, 106, 107
alanine, 7
alanine aminotransferase, 7
ALARA, 11, 24
algorithm, 6, 29, 42, 57, 59, 63, 65
ALT, 7, 9
alters, 36
aminoglycosides, 72, 75
amylase, 7, 16, 17, 27
anaerobic bacteria, 70, 78, 79
anastomosis, 13, 45, 46
anatomy, 33
anemia, 92
aneurysm, vii, x, 56, 62, 96, 97, 101, 103,
104, 106, 108, 109, 110
angiogenesis, 43
angiography, 14, 26
antibiotic, 69, 71, 72, 76, 78, 80
antibody, 106, 107
anticoagulant, 93
anticoagulation, 54
antimicrobial therapy, 72, 80
anuria, 36
aorta, 3, 20, 21, 99, 101
aortic injurie, 20, 21, 23, 29
aortic stenosis, 93
arrhythmia, 106, 110
artery(s), 14, 20, 26
aspartate, 7
assessment, 4, 7, 8, 10, 12, 21, 23, 33, 58,
102, 110
ATP, 34
atrial fibrillation, 34
aureus, viii, ix, 68, 70, 71, 76, 78, 84
awareness, 4, 21, 89
azotemia, 91
Index 112
B
bacteremia, 69, 74, 76, 77, 82, 83, 84, 85
bacteria, vii, viii, ix, x, 67, 68, 70, 76, 77,
78, 79, 84, 103, 104, 105, 106, 107, 109,
110
bacterial infection, 72
bacterial pathogens, 81
bacterial strains, 76
bactericidal, 69, 77, 84
bacteriostatic, 77
bacterium, 104, 105, 106
base, 50, 53
baumannii, 75, 76
benchmarks, 27
bending, 89
benefits, 15, 64
benign, 98
bicycle handlebar, 2, 3, 16, 20, 23, 97
bilateral, 65
bile, 92
bile duct, 92
binge drinking, 95
bleeding, 5, 7, 13, 14, 16, 17, 19, 21, 32, 33,
34, 35, 37, 43, 51, 52, 91, 94
bleeding time, 34, 35
blood, viii, 4, 5, 7, 10, 14, 34, 36, 37, 44, 52,
53, 54, 55, 68, 83, 91, 95
blood circulation, viii, 68
blood pressure, 37, 91
blood stream, 83
blood transfusion(s), 14, 55
blush, 14, 26
bone(s), 2, 88, 94, 98, 105
bowel, 3, 12, 13, 22, 25, 38, 39, 41, 43, 45,
46, 47, 69, 92, 95
bowel obstruction, 22, 69, 92, 95
brain, ix, 2, 87, 94
Brazil, 75
breakdown, 36, 53
breathing, 90
breathing disturbances, 90
burn, 57
bypass graft, 97, 101
C
CAM, 105
cancer, 10, 24
candidates, ix, 68, 78
capsule, 105
carbapenem, ix, 68, 71, 73, 74, 75, 78, 82,
83
cardiac output, 36
cardiac tamponade, 8
cardiovascular disease(s), x, 103, 104, 106,
107, 110
cartilaginous, 18
catheter, 4, 40, 84, 85
cautionary report, 83
cephalosporin, 84
Chicago, 51
child abuse, 4, 23
childhood, vii, viii, 2, 4
children, vii, 1, 2, 3, 4, 5, 6, 7, 8, 10, 11, 12,
13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23,
24, 25, 26, 27, 28, 29, 70, 79, 97, 102
China, 73, 81, 82
cholecystectomy, 93, 96
cholecystitis, 92
chronic renal failure, 93
cirrhosis, 53
classes, 74
classification, 17, 38, 39
cleaning, 43
climate, 52
clinical assessment, 4
clinical diagnosis, 16
clinical examination, 94
clinical isolate, 71, 80, 84
clinical presentation, 16
closure, viii, 31, 33, 38, 39, 40, 41, 42, 43,
44, 45, 46, 47, 48, 49, 50, 56, 57, 58, 59,
61, 62, 63, 64, 65, 71
coagulopathy, 11, 13, 33, 34, 35, 43, 48, 51,
52, 53, 54, 55
cocoon, 48
cognitive impairment, 89, 100
colectomy, 93
colistin, ix, 68, 74, 75, 76, 82, 83
Index 113
collaboration, viii, 31
collagen, 50
collisions, 20, 22
colon, 69, 70, 71, 72, 78, 92, 95
colonization, 49
colostomy, 41
combination therapy, 75
commercial, 43
common sense, 38
communication, 11
community(s), ix, 5, 33, 71, 81, 87, 88, 89,
90, 97, 99, 100
compartment syndrome, viii, 31, 38, 56, 57,
64
competitive sport, 15
complement, 110
complexity, 18
complications, x, 13, 14, 16, 18, 41, 44, 45,
48, 49, 51, 53, 60, 64, 69, 88, 97
compression, 2, 3, 20, 69
computed tomography, vii, 1, 9, 23, 24, 28,
98, 102
conditioning, 38
conduction, 34
conjugative plasmid, 81
consciousness, 6
consensus, viii, 31
consumption, 35
contamination, 33, 38, 41, 44, 48, 49, 72, 78
contrast-enhanced ultrasound, 10, 24
controversies, 17, 79
contusion, 3, 89, 99
correlation, 47
cost, 11, 13, 25, 41, 78, 98
cotton, 32
cough, 95
creatinine, 93
CT scan, 3, 8, 10, 14, 16, 19, 21, 95
culture, 72
cure, 77
cyst, 17
cysteine, 105
cytokines, 104
D
daily living, 89
deaths, 2, 74, 98
debridement, 48
defects, 47, 49, 64, 65
deficiency, ix, 68, 74
deficit, 37, 53
degradation, 105
dehiscence, 45
dendritic cell, 108
depression, 90
depth, 106
dermis, 64
descending colon, 92
destruction, 104, 110
detection, 53, 102
diabetes, 92
dialysis, 76, 77, 85
diaphragm, 2, 20, 43
diaphragmatic hernia, 29
Diaphragmatic Injuries, 19
diarrhea, 92
differential diagnosis, 55
disability, 89
disease progression, 104
diseases, 2, 104
disorder, 104
distribution, 29
diversity, 110
diverticulitis, 95
dizziness, 89
donors, 49
double-blind trial, 71
drainage, 17, 29, 44, 46, 61, 77
dressings, 45, 59, 62
drugs, 34, 76, 79
dyspnea, 92
E
E. coli, viii, 68, 69, 70, 71, 73
ECG, 91
edema, 16, 39, 40, 41, 44, 50, 51, 57
Index 114
effluent, 46
ELISA, 106
e-mail, 87
emboli, vii, 1, 14, 26, 101
embolization, vii, 1, 14, 26, 101
emergency, ix, 8, 10, 56, 59, 64, 87, 89, 90,
91, 92, 93, 94, 95
emergency physician, 89
emerging, 2, 71, 81, 84
endoscopic retrograde
cholangiopancreatography, 17
energy, 16, 19, 21, 60, 97
energy transfer, 16
England, 32, 51
enlargement, 16
environment, 43, 44, 71
enzymatic activity, 34
enzyme(s), 16, 27, 73, 74, 81
epidemic, 22
epidemiologic, 11
epidemiology, vii, viii, ix, 2, 68
epigastrium, 16
ERCP, 17, 28
ertapenem resistance, 79
Europe, 10
evacuation, 42
evidence, viii, 6, 9, 14, 19, 25, 32, 35, 55,
59, 78, 80, 93
evolution, 32, 79
examinations, 10, 17
expertise, 5, 9, 10, 14, 15, 18, 20, 21
exposure, vii, 1, 8, 24, 32, 34
external oblique, 50
extracellular matrix, 104
extravasation, 10, 12, 14
F
faecalis (E. faecalis), ix, 68
false negative, 9
families, viii, 1, 5, 11
fascia, 32, 33, 38, 39, 40, 41, 42, 44, 45, 46,
47, 48, 50, 62, 69
FAST, viii, 1, 5, 7, 8, 9, 23, 24
fat, 2, 16, 18
femur, 4, 5, 8
fever, 91
fibrinogen, 34, 36, 53
fibrosis, 69
filtration, 36
Finland, 88, 101
fistulas, 45, 46, 59, 61
flank, 18
flora, 70, 78, 110
fluid, viii, 5, 6, 7, 8, 10, 12, 14, 31, 36, 40,
41, 42, 43, 44, 45, 92, 94
fluoroquinolones, 75
Focused Abdominal Sonography for
Trauma, 7
Food and Drug Administration (FDA), 76,
77
football, 15
force, 4, 18, 20
Ford, 23
formation, 28, 35, 41, 43, 45, 47, 49, 70
formula, 46
fractures, ix, 4, 5, 19, 23, 60, 87, 88, 91, 94,
96, 98, 101
France, v, 31, 83
fresh frozen plasma, 36
frostbite, 52
G
gallbladder, ix, 88, 92, 95, 99, 100, 101
gallstones, 95
gangrene, viii, 67
gastrointestinal tract, 38, 48, 70
general surgeon, 14
general surgery, 56
genes, ix, 68
gingival, 104
gland, 16
glycopeptides, 76
grades, 17
grading, vii, 1, 14
granules, 69
gravity, 22
growth, 43, 47, 50
Index 115
guidelines, vii, 1, 5, 11, 15, 25, 26, 27, 36,
72, 80
H
healing, 13, 39, 45, 47, 61
health, 109
healthy sites, 105
heart rate, 6
heat loss, 34, 44
height, 97
hematocrit, 9
hematoma(s), ix, 3, 12, 16, 21, 60, 69, 88,
91, 92, 93, 94, 96
hematuria, 7, 9, 18, 22, 29, 93, 97
hemodynamic instability, 5, 6, 19
hemoglobin, 14, 91, 94, 95, 97
hemorrhage, 5, 10, 11, 13, 36, 69, 93
hemostasis, 34, 35, 48, 54
hernia, 47, 49, 50, 57, 58, 64, 65, 78
hernia repair, 50, 64, 65
high risk patients, 48
history, 3, 21, 26, 59, 63, 88, 89, 90, 92
homeostasis, 34
hospitalization, viii, 1, 22, 45
host, 104
human, 49, 53, 64, 104, 108, 109, 110
husband, 97
hydrolysis, 34, 73
hydronephrosis, 96
hypernephroma, 93
hypertension, 37, 38, 48, 56, 90, 92, 93
hypotension, 4, 32, 36, 89
hypothermia, 11, 33, 34, 35, 48, 51, 52, 53,
55
hypovolemia, 4
hypovolemic shock, 91
hypoxia, 33
I
ideal, 21, 41, 43, 48
identification, vii, 1, 5, 7, 23, 24, 44, 97
ileostomy, 41, 93
ileum, 95
image(s), 10, 11, 24
imaging modalities, vii, 1, 11
immune response, 108
impairments, 88
Importantly, 76, 95
improvements, vii, 1, 33
in vitro, 34, 74, 76, 82
in vivo, 77
incidence, ix, 61, 72, 87, 88, 98, 99, 109
incisional hernia, 63
individuals, 88
induction, 109
infants, 4, 5
infarction, viii, 51, 67
infection(s), vii, viii, ix, 13, 49, 60, 63, 64,
67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77,
78, 79, 80, 81, 82, 83, 84, 85, 104, 105,
109
inferiority, 76
inflammation, 104
inflammatory bowel disease, 64
inflammatory responses, 104
inhibition, 35
inhibitor, 73, 74, 75, 83, 108
injury prevention, 21
insecurity, 88
insomnia, 88
institutions, 5
integration, 62
integrity, 12, 46
intensive care unit, 81
interface, 43, 47
intervention, vii, 1, 13, 14, 15, 17, 18, 19,
21
Intestinal Injuries, 12
intestinal perforation, 69, 97, 102
intestine, 96
intra-abdominal abscess, vii, viii, 67, 70, 71
intraperitoneal daptomycin, 85
intravenously, 72
ionizing radiation, vii, 1, 10
irrigation, 40, 71
ischemia, 3, 6, 12, 21, 47, 59, 97, 101
Islam, 27
Index 116
isolation, 7, 12, 46
Israel, 87, 100
Italy, 31
J
Japan, 103
joint pain, 89
Jordan, 80
K
kidney(s), 18, 36, 93, 94, 99
kill, 2, 83
Klebsiella pneumoni, viii, 68, 79, 81, 82
Klebsiella pneumoniae, viii, 68, 79, 81, 82
KPC-2, 74
KPC-3, 74
L
laboratory studies, 6, 7, 23
laceration, viii, 16, 67, 88, 97
lactate level, 37
laparoscopy, 9, 12, 13, 29
laparotomy, 5, 9, 12, 13, 14, 20, 21, 37, 44,
45, 52, 56, 57, 59, 60, 63, 71, 95
lapbelt injuries, 3
lead, 16, 35, 41, 48, 61, 69
leakage, 41, 45, 70
leaks, 17
legs, 89
lesions, 24, 47
ligament, 43
light, 32
linezolid, ix, 68, 76, 77, 85
liver, 4, 6, 8, 9, 13, 14, 19, 24, 25, 26, 27,
32, 64
Liver, 13, 15, 53
liver transplant, 64
localization, 109
low risk, 6, 24
lumbar spine, 24
lumen, 38
Luo, 82
lying, 44
lysis, 55
M
magnetic resonance, 9, 17
magnetic resonance imaging, 9
majority, 17, 19, 20, 71
malnutrition, 45, 46
manipulation, 47
mass, 69, 78, 97
matrix, x, 49, 64, 65, 103, 104, 108, 109
matrix metalloproteinase(s), x, 103, 104,
108, 109
matter, 25
measurement, 55
media, 104
median, 11, 75
mediastinitis, 79
medical, ix, 37, 38, 87, 93, 94
medical history, 93
medicine, 91, 94
membrane protein, 80
mesentery, 3, 38
meta-analysis, 24, 77, 85, 90, 100
Metabolic, 60
metabolic acidosis, 33, 34
metabolic responses, 52
metabolism, 34, 36
metalloproteinase, 108
mice, 54, 105, 106, 109
microbiota, 110
migration, 43
MMP(s), 104, 105, 106
MMP-2, 105, 106
models, 105
molecules, 84
morbidity, 12, 13, 25, 26, 71, 72, 88
mortality, 2, 14, 19, 20, 35, 52, 54, 71, 72,
75, 77, 88, 98, 102
mortality rate, 35
MRCP, 17
MRI, 9, 97
multi-resistant, 77
Index 117
muscle mass, 89
muscles, 18, 32
mutation(s), ix, 68, 71
myocardial infarction, 109
N
nausea, 16
necrosis, 3, 6, 47, 69
necrotizing fasciitis, 69, 72, 78
nephrectomy, 93
neurogenesis, 43
nitrogen, 46
nonaccidental trauma, 4, 16
nonoperative management, 5, 7, 13, 14, 15,
18, 19, 26, 27, 28
North America, 2, 10
nursing, 41, 88, 99
nursing home, 88, 99
nutrition, 13, 17, 46, 60
nutritional status, 46
O
obesity, 90
obstruction, 12, 45, 95
oral cavity, 104, 110
organ(s), vii, viii, 1, 2, 3, 4, 5, 6, 7, 9, 10,
12, 13, 14, 18, 21, 24, 27, 29, 34, 35, 37,
38, 47, 48, 59, 67, 69, 72, 89, 90, 93, 94,
97, 98, 99, 102
organism, 73, 75
orthostatic hypotension, 89
osteoporosis, 94
overproduction, 80
overtime, 50
ownership, 25
P
pain, 9, 12, 16, 20, 69, 91, 92, 94, 95, 97
palpation, 6
PAN, 98, 102
pancreas, 16, 27
Pancreatic Injuries, 16
pancreatic pseudocyst, 17
pancreatitis, viii, 16, 67
patents, 19
pathogenesis, 55, 109
pathogens, vii, x, 70, 71, 73, 74, 76, 78, 80,
81, 84, 103, 104, 106, 107, 110
pathophysiological, 34, 105
pathophysiology, x, 54, 103, 107
pathway, 35, 54
pelvis, 2, 5, 8, 94
penicillin, 69, 75, 77
perforated viscus, 9
perforation, viii, 3, 6, 12, 25, 67, 71, 97, 102
perfusion, 34
pericardial sac, 7
periodontal, vii, x, 103, 104, 105, 106, 107,
108, 109, 110
periodontal disease, 104, 105, 108, 109, 110
periodontitis, v, vii, x, 103, 104, 105, 106,
107, 108, 109, 110
peripheral neuropathy, 88
peripheral vascular disease, 109
peritoneal cavity, 7, 38, 70, 71
peritoneal lavage, 7, 13
peritonitis, vii, viii, 9, 61, 63, 67, 69, 70, 71,
72, 76, 77, 84, 85, 95
permit, 17
pH, 34, 37
pharmaceutical, 84
pharmacokinetics, 83
physical abuse, 4
physicians, ix, 11, 15, 68, 89, 94, 98
physiology, 33
pigs, 53
placebo, 80
plaque, 106
plasmid, 73, 81
platelet count, 34, 35
platelets, 35, 55
pleural effusion, 19, 91
PM, 65
pneumonia, 54, 69, 76, 77
polypropylene, 49, 64
polyurethane, 42
Index 118
population, 2, 3, 7, 10, 20, 22, 39, 83, 88,
99, 107
porin genes, ix, 68
predictive validity, 100
prevention, 37, 42, 43, 59, 71
principles, 34, 60, 61
probability, 44
producers, 71, 73, 74, 78
proliferation, 43
propagation, 34
prophylaxis, 69
protection, 4, 18
proteins, 46, 75
pseudocyst, 16, 17, 28
Pseudomonas aeruginosa, viii, 68, 80, 82
psychotropic drugs, 89
PTFE, 41
pubis, 96
public health, 22, 81
pumps, 71, 76
pus, 69, 70, 79
pyuria, 91
Q
quality improvement, 27
quality of life, 41, 88
questioning, 16
R
radiation, 8, 10, 11, 24
reality, 2
rebound tenderness, 95
receptor(s), x, 34, 35, 103, 105, 109
recognition, x, 13, 78, 88
recommendations, 59, 80
reconstruction, 19, 33, 48, 49, 50, 57, 59,
64, 65
recovery, 13, 47, 59
rectus abdominis, 65
recurrence, 49, 93
red blood cells, 5, 9, 36, 55
renal contusion, 19, 96
renal failure, 36, 55
Renal Injuries, 18
repair, 13, 19, 20, 21, 25, 29, 45, 46, 49, 56,
62, 63, 64, 71, 80
requirement(s), 35, 36, 53
researchers, 8
resection, 13, 45, 46, 48, 93
reserves, 32
resistance, ix, 36, 68, 70, 71, 73, 74, 75, 76,
78, 79, 81, 82, 83, 84
resolution, 18, 105
resource utilization, 26
resources, viii, 1, 5, 11, 13, 14, 15, 18, 21
respiration, 32
respiratory distress syndrome, viii, 68
respiratory rate, 34
response, 5, 35, 72, 75, 105, 108
responsiveness, 34
restrictions, 6
risk(s), vii, x, 2, 4, 6, 7, 8, 10, 12, 13, 15, 17,
19, 20, 24, 37, 38, 41, 43, 45, 46, 47, 51,
52, 53, 54, 59, 60, 63, 71, 72, 80, 88, 89,
90, 97, 99, 100, 103, 104
risk factors, 37, 45, 46, 89, 90, 100
risk-taking, 2
S
safety, 22
saliva, 106
scapula, 91
Second World, 32
secretion, 104
sedative, 89
sensitivity, 6, 7, 8, 9, 16
sepsis, 11, 12, 13, 32, 45, 46, 48, 49, 50, 51,
57, 58, 59, 60, 63, 79
septic shock, viii, 68, 69, 93
Serratia marcescens, 73, 79
Serratia marcescens comediated, 79
serum, 7, 9, 16, 17, 27, 34, 106, 107, 110
services, 13
sex, 106
shock, 32, 35, 52, 54
showing, 91, 92, 93